Actively Recruiting
Comparing a Simplified Versus Divided-Dose Tranexamic Acid Treatment for Severe Traumatic Bleeding A Multicenter Randomized Pilot Study
Led by Second Affiliated Hospital, Zhejiang University, School of Medicine · Updated on 2026-10-09
60
Participants Needed
3
Research Sites
4 weeks
Total Duration
AI-Summary
What This Trial Is About
Trauma causes millions of deaths worldwide each year, with uncontrolled bleeding within 24 hours after injury being the leading cause of death for trauma patients. About one-third of these patients present with trauma-induced coagulopathy upon admission. Tranexamic Acid TXA is a medication that helps prevent blood clots from breaking down, reducing blood loss and improving bleeding control. While the divided-dose TXA regimen is commonly used, its complexity and time sensitivity make it difficult to fully implement, especially in emergency or battlefield settings. This trial compares two TXA regimens for patients with severe traumatic hemorrhage a simplified single 2 g loading dose given intravenously within 3 hours after injury without a second dose, versus the standard divided regimen of a 1 g loading dose followed by a maintenance infusion of 1 g over 8 hours. Both regimens are administered intravenously shortly after injury, aiming to evaluate if the simplified regimen is as effective and safe as the divided regimen while being easier to deliver in urgent care situations. Participants will be monitored during their hospital stay, with researchers tracking safety outcomes including thrombotic events such as deep vein thrombosis, pulmonary embolism, seizures, hypotension, kidney injury, and mortality. Blood clotting efficiency and blood product usage will also be assessed. The study aims to gather data on safety, feasibility, and treatment adherence to inform a larger trial. The total participation duration varies depending on hospital stay and follow-up, with the primary outcome focusing on thrombotic events during hospitalization.
CONDITIONS
Brief Title
The Safety of Simplified Tranexamic Acid Regimen
Research Team
Y
yongan xu
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here